Kathmandu University   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Dhulikhel Nepal (1991)

Organization Overview

First Clinical Trial
2014
NCT02708446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dhulikhel Hospital | Kathmandu Medical College | Kathmandu Medical College and Teaching Hospital | Kathmandu University School of Medical Sciences

Active Ingredients

Drugs in Phase 4 Trials (2)

mifepristone (mifeprex) (2 trials)

misoprostol (cytotec) (2 trials)

Drugs in Phase 3 Trials (1)

cobalamin (1 trial)

Drugs in Phase 1 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Other Trials (3)

lidocaine (xylocaine) (1 trial)

nicotinamide (1 trial)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vitamin B 12 Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7